Pulmonx Corporation
LUNG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$13,957 | -$15,173 | -$14,448 | -$13,175 |
| Dep. & Amort. | $246 | $399 | $278 | $294 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,166 | $0 | $5,612 | $5,523 |
| Change in WC | -$128 | $4,667 | -$4,783 | $789 |
| Other Non-Cash | $511 | $6,152 | $119 | -$161 |
| Operating Cash Flow | -$8,162 | -$3,955 | -$13,222 | -$6,730 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$89 | -$49 | -$301 | -$111 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$1,730 | -$3,921 | -$1,494 |
| Inv. Sales/Matur. | $8,800 | $7,250 | $20,535 | $15,672 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $8,711 | $5,471 | $16,313 | $14,067 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | -$48 | $0 | -$49 |
| Stock Issued | $0 | $28 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $182 | $0 | $664 | $111 |
| Financing Cash Flow | $181 | -$20 | $664 | $62 |
| Forex Effect | $355 | -$583 | -$105 | $193 |
| Net Chg. in Cash | $1,085 | $913 | $3,650 | $7,592 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75,725 | $74,812 | $71,162 | $63,570 |
| End Cash | $76,810 | $75,725 | $74,812 | $71,162 |
| Free Cash Flow | -$8,251 | -$4,004 | -$13,523 | -$6,841 |